Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation
- 26 May 2006
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 28 (9), 808-812
- https://doi.org/10.1002/hed.20427
Abstract
Background Concurrent chemoradiation therapy has been demonstrated to be effective as an organ-sparing treatment for select advanced head and neck squamous cell carcinoma (HNSCC). However, this treatment modality is not without side effects. One side effect is the formation of upper esophageal strictures. As concurrent chemoradiation treatment is used more frequently, it is important to identify risk factors associated with stricture formation. Methods A retrospective chart review of all patients who had undergone definitive concurrent chemoradiation treatment between 1989 and 2002 was performed. Exclusion criteria included death within 1 year or persistent/recurrent disease that required surgical salvage at the primary site. The outcome measure was stricture formation as determined by both objective findings (barium swallow or endoscopy) and the need for dilation after treatment. Results Of the 222 patients in this cohort, there were enough data for 199 patients to assess for stricture formation. Strictures developed in a total of 41 patients (21%). Significant predictive factors were a twice-daily (BID) radiation fractionation (p = .007), female sex (p = .015), and a hypopharyngeal primary site (p = .01). Age and tumor extent were not significant factors in stricture formation (p = .15 and p = .23, respectively). Conclusions Symptomatic strictures occur in 21% of patients undergoing concurrent chemoradiation for HNSCC. Female sex, BID radiation fractionation, and a hypopharyngeal primary site are significant predictive factors for stricture formation. © 2006 Wiley Periodicals, Inc. Head Neck, 2006Keywords
This publication has 17 references indexed in Scilit:
- Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal CancerNew England Journal of Medicine, 2003
- Voice and Swallowing in Patients Enrolled in a Larynx Preservation TrialJAMA Otolaryngology–Head & Neck Surgery, 2003
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerJournal of Clinical Oncology, 2003
- Combined chemotherapy and radiation therapy for head and neck malignanciesCancer, 2002
- Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx CarcinomaJNCI Journal of the National Cancer Institute, 1999
- Pharyngeal Transport Dysfunction Consequent to an Organ-Sparing ProtocolJAMA Otolaryngology–Head & Neck Surgery, 1999
- Aggressive Concurrent Chemoradiotherapy for Squamous Cell Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 1999
- Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 1998
- Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.Journal of Clinical Oncology, 1998
- A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary resultsHead & Neck, 1997